Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(4-Bromobenzyloxy)piperidine, N-BOC protected 97% is a chemical compound that features a piperidine ring with a 4-bromobenzyloxy substituent and a tert-butyl carbamate (BOC) protecting group. 4-(4-Bromobenzyloxy)piperidine, N-BOC protected 97% is characterized by its high purity of 97% and is a valuable intermediate in the synthesis of various pharmaceuticals and bioactive molecules.
Used in Pharmaceutical Industry:
4-(4-Bromobenzyloxy)piperidine, N-BOC protected 97% is used as a key reactant for the preparation of MS049, a potent, selective, and cell-active dual inhibitor of protein arginine methyltransferase 4 (PRMT4) and protein arginine methyltransferase 6 (PRMT6). These enzymes play crucial roles in various cellular processes, including gene expression regulation, signal transduction, and protein-protein interactions. Inhibition of PRMT4 and PRMT6 has been implicated in the treatment of various diseases, such as cancer and inflammatory disorders, making MS049 a promising therapeutic agent.
Additionally, the N-BOC protected 4-(4-Bromobenzyloxy)piperidine can be utilized as a building block in the synthesis of other bioactive compounds with potential applications in drug discovery and development. The presence of the BOC protecting group allows for selective deprotection and further functionalization of the piperidine core, enabling the creation of diverse chemical libraries for screening and optimization.

930111-10-7

Post Buying Request

930111-10-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

930111-10-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 930111-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,1,1 and 1 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 930111-10:
(8*9)+(7*3)+(6*0)+(5*1)+(4*1)+(3*1)+(2*1)+(1*0)=107
107 % 10 = 7
So 930111-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H24BrNO3/c1-17(2,3)22-16(20)19-10-8-15(9-11-19)21-12-13-4-6-14(18)7-5-13/h4-7,15H,8-12H2,1-3H3

930111-10-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-[(4-bromophenyl)methoxy]piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names F2158-1454

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:930111-10-7 SDS

930111-10-7Downstream Products

930111-10-7Relevant articles and documents

N-(3-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PHENYL)BENZAMIDE DERIVATIVES

-

Page/Page column 98; 99; 127, (2019/10/23)

The invention relates to compounds of the formula (I) (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.

Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6

Shen, Yudao,Szewczyk, Magdalena M.,Eram, Mohammad S.,Smil, David,Kaniskan, H. ümit,Ferreira De Freitas, Renato,Senisterra, Guillermo,Li, Fengling,Schapira, Matthieu,Brown, Peter J.,Arrowsmith, Cheryl H.,Barsyte-Lovejoy, Dalia,Liu, Jing,Vedadi, Masoud,Jin, Jian

, p. 9124 - 9139 (2016/10/22)

Well-characterized selective inhibitors of protein arginine methyltransferases (PRMTs) are invaluable chemical tools for testing biological and therapeutic hypotheses. Based on 4, a fragment-like inhibitor of type I PRMTs, we conducted structure-activity

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 930111-10-7